๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation

โœ Scribed by Qianqian Zhu, Lin Zhou, Zhe Yang, Mingchun Lai, Haiyang Xie, Liming Wu, Chunyang Xing, Feng Zhang, Shusen Zheng

Book ID
113093678
Publisher
Springer US
Year
2011
Tongue
English
Weight
673 KB
Volume
29
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Tumor recurrence following liver transpl
Tumor recurrence following liver transplantation for hepatocellular carcinoma: Role of tumor proliferation status
โœ Aileen E. Marshall; Simon M. Rushbrook; Sarah L. Vowler; Christopher R. Palmer; ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 297 KB

The selection of patients with hepatocellular carcinoma for liver transplantation is currently based on the size and number of tumors to minimize the risk of recurrence. These criteria measure tumor bulk but may not reflect tumor behavior accurately. A biological marker of tumor behavior could aid w

Total tumor volume predicts risk of recu
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma
โœ Christian Toso; James Trotter; Alice Wei; David L. Bigam; Shimul Shah; Joshua La ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 241 KB

Criteria for the selection of candidates for liver transplantation in the presence of hepatocellular carcinoma (HCC) should accurately predict posttransplant recurrence while not excluding excessive numbers of patients from candidacy. Existing criteria are challenged by the limited accuracy of radio

Predicting the risk of tumor recurrence
Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma
โœ J W Marsh; A Casavilla; S Iwatsuki; I Dvorchik; M Subotin; V Balan; J Rakela; V ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 1 views

be either higher or lower than 1, i.e., having serological mark-to the exposure of interest, constitute a valid and well-accepted comparison group, which has been used in countless ers of infection by hepatitis B and C viruses could be either ''protective'' or ''predisposing'' factors for aplastic a